Latest filing published 21 Mar 2014 for NOVAVAX INC, €3.7M.
Insider track record
No signal scores available.
Cadila Pharmaceuticals Ltd: trading record in brief
This profile gathers the share dealings of Cadila Pharmaceuticals Ltd in Novavax Inc. Over a trading history stretching from 19 March 2014 to 21 March 2014, the count stands at 3 filings.
Every open-market trade on record is a sale: 3 sales worth €10.7M.
On 21 March 2014 came the latest disclosure, an open-market sale for €3.7M in Novavax Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 1 day. For comparison, the SEC allows two business days to file a Form 4. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Cadila Pharmaceuticals Ltd
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 1,000,000 shares@ US$5.17Common StockSEC:0001209191-14-022507:0
- 1,000,000 shares@ US$4.99Common StockSEC:0001209191-14-022507:1
- 1,000,000 shares@ US$4.69Common StockSEC:0001209191-14-022507:2
3 of 3 declarations
